Mark Kagan
Impact in
- Chemical Health and Safety top 5%
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
- Oncology 4
- Co-authors
- Klaus D. Brunnemann (3 shared papers)Jonathan E. Cox (2 shared papers)Dietrich Hoffmann (3 shared papers)Stephen S. Hecht (4 shared papers)Steven G. Carmella (3 shared papers)Heyi Li (2 shared papers)Assieh A. Melikian (2 shared papers)Shobha A. Akerkar (1 shared paper)
- Journals
- Drug Metabolism and Disposition (3 papers)Blood (2 papers)Carcinogenesis (2 papers)Frontiers in Immunology (1 paper)Chemical Research in Toxicology (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mark Kagan
23 papers receiving 794 citations
Peers
Comparison fields: 5 of 111
- Chemical Health and Safety 16
- Cancer Research 315
- Health, Toxicology and Mutagenesis 205
- Pharmacology 75
- Spectroscopy 83
Countries citing papers authored by Mark Kagan
This map shows the geographic impact of Mark Kagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kagan more than expected).
Fields of papers citing papers by Mark Kagan
This network shows the impact of papers produced by Mark Kagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kagan. The network helps show where Mark Kagan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Kagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 133 | |
| 2 | 1991 | 106 | |
| 3 | 2000 | 99 | |
| 4 | Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. | 1990 | 91 |
| 5 | 2018 | 90 | |
| 6 | 1999 | 87 | |
| 7 | 2012 | 52 | |
| 8 | 1989 | 43 | |
| 9 | 1991 | 24 | |
| 10 | 2005 | 21 | |
| 11 | 2012 | 20 | |
| 12 | 2015 | 15 | |
| 13 | 2017 | 14 | |
| 14 | 2024 | 12 | |
| 15 | 1989 | 11 | |
| 16 | 2009 | 9 | |
| 17 | 2021 | 4 | |
| 18 | 2024 | 2 | |
| 19 | Quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone released from human haemoglobin as a dosimeter for exposure to tobacco-specific nitrosamines. | 1991 | 2 |
| 20 | 1991 | 1 |
About Mark Kagan
Mark Kagan is a scholar working on Molecular Biology, Oncology, Spectroscopy, Pharmacology and Physiology, having authored 23 papers that have together received 839 indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Analytical Chemistry and Chromatography (3 papers), Advanced Chemical Sensor Technologies (3 papers), Energy, Environment, and Transportation Policies (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Chemical Health and Safety (16 citations), Cancer Research (315 citations), Health, Toxicology and Mutagenesis (205 citations), Pharmacology (75 citations) and Spectroscopy (83 citations). Mark Kagan has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Klaus D. Brunnemann, Jonathan E. Cox, Dietrich Hoffmann, Stephen S. Hecht, Steven G. Carmella, Heyi Li, Assieh A. Melikian, Shobha A. Akerkar, Gary D. Stoner and James H. Resau. Their work appears in journals such as Drug Metabolism and Disposition, Blood, Carcinogenesis, Frontiers in Immunology and Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.